COVID-19, Other Factors Contribute to Changes in Prescription-Drug Spending
|
|
The COVID-19 pandemic skewed statistics on prescription spending, making it more difficult to see longer term trends. Find out why the report from the American Society of Health-System Pharmacists suggests that an increase in use of biosimilars, many new cancer medications, and increased approvals of specialty medications are so important for the future.
|